Showing results (1491-1500 of 10,561) with videos related to
Sort By:
Pageof 1,057
Thrombosis Research|June 4, 2013
Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin dosesDavide Di Fusco, Cinzia Ciccacci, Sara Rufini, et al.Thrombosis Research|June 5, 2013
Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patientsMark van Geffen, Natascha C J Mathijssen, Pål A Holme, et al.Thrombosis Research|June 27, 2013
Nonadherence with INR monitoring and anticoagulant complicationsDaniel M Witt, Thomas Delate, Nathan P Clark, et al.Thrombosis Research|April 30, 2013
The isolation of fibrinogen monomer dramatically influences fibrin polymerizationLihong Huang, Susan T LordThrombosis Research|March 15, 1990
Local activation of the coagulation and fibrinolysis systems in lung diseaseB Nakstad, T Lyberg, O H Skjønsberg, et al.Thrombosis Research|March 15, 1990
Thiolprotease inhibitor, EST, can inhibit thrombin-induced platelet activationH Ishii, M Kuboki, J Fujii, et al.Thrombosis Research|March 15, 1990
Effect of a highly selective plasma-kallikrein synthetic inhibitor on contact activation relating to kinin generation, coagulation and fibrinolysisK Wanaka, S Okamoto, M Bohgaki, et al.Thrombosis Research|July 6, 2013
Selective tissue factor/factor VIIa Inhibitor, ER-410660, and its prodrug, E5539, have anti-venous and anti-arterial thrombotic effects with a low risk of bleedingTadashi Nagakura, Kimiyo Tabata, Kazunobu Kira, et al.Thrombosis Research|July 9, 2013
Antiplatelet factor 4/heparin antibodies in patients with gram negative bacteremiaGeorgios Pongas, Swapan Kumar Dasgupta, Perumal ThiagarajanThrombosis Research|March 30, 2013
Innovative coagulation factors: albumin fusion technology and recombinant single-chain factor VIIIStefan SchultePageof 1,057